Defective E-cadherin/catenin complexes in human cancer

被引：0
作者：
Van Aken E. [1 ]
De Wever O. [2 ]
Da Rocha C.A. [3 ]
Mareel M. [2 ]
机构：
[1] Department of Ophthalmology, Ghent University Hospital, 9000 Gent
[2] Laboratory of Experimental Cancerology, Ghent University Hospital, 9000 Gent
[3] Institute of Molecular Pathology and Immunology, University of Porto, 4200 Porto, Rua Roberto Frias s/n
来源：
Virchows Archiv | 2001年 / 439卷 / 6期
关键词：
Cadherin; Cancer; Catenin; Eye; Thyroid;
D O I：
10.1007/s004280100516
中图分类号：
学科分类号：
摘要：
Cancer is caused by a series of genomic changes leading directly or indirectly to disturbance of growth, differentiation and tissue integrity. Genomic, transcriptional or posttranscriptional alterations of E-cadherin/catenin complexes that are implicated in various steps of cancer development comprise mutational inactivation, transcriptional downregulation of E-cadherin sometimes accompanied by upregulation of N-cadherin, proteolysis of E-cadherin and posttranslational stabilisation of β-catenin and plakoglobin. The E-cadherin/catenin complex serves not only cell-cell adhesion but also transduces signals to the nucleus and to the cytoskeleton, either directly or through its connections with multiple other complexes. We review here the expression of E-cadherin/catenin in human cancers, emphasising methods of observation and prognostic interpretation of results. This is illustrated in thyroid lesions from the benign follicular adenoma to the extremely malignant anaplastic carcinoma. The eye is an organ largely neglected by students of cadherins and catenins. The implication of a variety of members of these molecular families in the embryonic development of the eye strongly suggests that disturbances of cadherin/catenin complexes are crucial also in the development of ocular tumours.
引用
收藏
页码：725 / 751
页数：26
相关论文
共 153 条
  • [1] Akimoto T., Mitsuhashi N., Saito Y., Ebara T., Niibe H., Effect of radiation on the expression of E-cadherin and α-catenin and invasive capacity in human lung cancer cell line in vitro, Int J Radiat Oncol Biol Phys, 41, pp. 1171-1176, (1998)
  • [2] Akslen L.A., LiVolsi V.A., Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma, Cancer, 88, pp. 1902-1908, (2000)
  • [3] Akslen L.A., Varhaug J.E., Oncoproteins and tumor progression in papillary thyroid carcinoma. Presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival, Cancer, 76, pp. 1643-1654, (1995)
  • [4] Anastasiadis P.Z., Reynolds A.B., The p120 catenin family: Complex roles in adhesion, signaling and cancer, J Cell Sci, 113, pp. 1319-1334, (2000)
  • [5] Anastasiadis P.Z., Moon S.Y., Thoreson M.A., Mariner D.J., Crawford H.C., Zheng Y., Reynolds A.B., Inhibition of RhoA by p120 catenin, Nat Cell Biol, 2, pp. 637-644, (2000)
  • [6] Andre F., Rigot V., Thimonier J., Montixi C., Parat F., Pommier G., Marvaldi J., Luis J., Integrins and E-cadherin cooperate with IGF-I to induce migrartion of epithelial colonic cells, Int J Cancer, 83, pp. 497-505, (1999)
  • [7] Arregui C., Pathre P., Lilien J., Balsamo J., The nonreceptor tyrosine kinase Fer mediates cross-talk between N-cadherin and β1-integrins, J Cell Biol, 149, pp. 1263-1273, (2000)
  • [8] Asano K., Kubo O., Tajika Y., Takakura K., Suzuki S., Expression of cadherin and CSF dissemination in malignant astrocytic tumors, Neurosurg Rev, 23, pp. 39-44, (2000)
  • [9] Asgeirsson K.S., Jonasson J.G., Tryggvadottir L., Olafsdottir K., Sigurgeirsdottir J.R., Ingvarsson S., Ogmundsdottir H.M., Altered expression of E-cadherin in breast cancer: Patterns, mechanisms and clinical significance, Eur J Cancer, 36, pp. 1098-1106, (2000)
  • [10] Babich M., Foti L.R., E-cadherins identified in osteoblastic cells: Effects of parathyroid hormone and extracellular calcium on localization, Life Sci, 54, (1994)
12345678910